Open access
Sep 2026
Oveporexton for Narcolepsy Type 1 - Results from Two Phase 3 Trials.
Over a period of 12 weeks, oveporexton significantly improved measures of wakefulness, sleepiness, and cataplexy in participants with narcolepsy type 1.
Y. Dauvilliers, Emmanuel Mignot, J. Antczak et al.
· New England Journal of Medic... · 3 citations
· ⚡2